For decades, A1C has served as the gold standard for assessing long-term glucose control in people with diabetes. However, it tells only part of the story. Researchers are now exploring whether metabolic flexibility could become an important biomarker in diabetes, offering a deeper understanding of metabolic health than A1C alone. …
Read More »The New Diabetes Type Most Clinicians Have Never Heard Of: Why Type 5 Changes Everything
For decades, diabetes has been grouped into familiar categories such as type 1 diabetes, type 2 diabetes, gestational diabetes, and several secondary forms. However, growing international recognition of Type 5 diabetes, formerly known as malnutrition-related diabetes, is challenging long-held assumptions about diabetes classification. This newly recognized condition appears to follow …
Read More »Could Stem Cell Therapy Change Type 1 Diabetes Forever? Preparing for the Next Era of Care
For more than a century, insulin has been the foundation of type 1 diabetes care. However, even the best insulin pumps, continuous glucose monitors, and automated insulin delivery systems still cannot fully replace the body’s lost beta cells. That is why interest in stem cell islet transplant diabetes research continues …
Read More »The Diabetes Complication Nobody Sees Coming: Cognitive Decline in Midlife Adults
For decades, diabetes care has focused on preventing complications such as retinopathy, nephropathy, neuropathy, and cardiovascular disease. Yet another complication may be developing much earlier and often without obvious symptoms: diabetes-related cognitive decline. While memory loss and dementia have traditionally been viewed as concerns of older age, growing evidence suggests …
Read More »The First Disease-Modifying Treatment After a Type 1 Diabetes Diagnosis: Why Teplizumab Is Changing the Conversation
For decades, treatment after a type 1 diabetes diagnosis focused almost entirely on insulin replacement and blood glucose management. While advances in technology have improved care, clinicians have had few ways to address the autoimmune process driving beta-cell loss. That is beginning to change. With the FDA’s expansion of teplizumab-mzwv …
Read More »Is Diabetes Making People Age Faster? What the New Science Reveals
For decades, scientists have known that people with type 2 diabetes face a higher risk of heart disease, kidney disease, cognitive decline, and other age-related conditions. However, emerging research suggests these complications may be linked to something even more fundamental: accelerated biological aging in diabetes. In other words, diabetes may …
Read More »Could Hearing Loss Be an Early Warning Sign of Future Diabetes Complications?
For many people living with diabetes, complications such as retinopathy, nephropathy, and neuropathy are well-recognized concerns. However, growing evidence suggests that hearing loss may deserve a place on that list as well. Researchers are increasingly examining whether hearing loss reflects the same vascular and neurologic damage that contributes to complications …
Read More »Can Environmental Chemicals Increase Diabetes Risk? What Emerging Research Suggests
Growing evidence suggests that diabetes risk may involve more than genetics, diet, and physical inactivity alone. Researchers are now studying whether environmental chemicals could influence metabolic health in ways that contribute to insulin resistance and type 2 diabetes. While the science is still developing, interest in how environmental exposures may …
Read More »GLP-1 Drugs and Parkinson’s Disease: Could Metabolic Therapy Influence Neurodegeneration?
What if a medication designed to lower blood sugar could also help protect the brain? That question is driving growing interest among researchers studying the connection between GLP-1 drugs and Parkinson’s disease. Scientists are now exploring whether therapies originally developed for type 2 diabetes and obesity may influence inflammation, neuronal …
Read More »GLP-1s and Muscle Quality: Beyond Lean Mass Preservation
Weight loss conversations often focus on a simple question: how much lean mass is preserved? However, emerging research suggests that the story is more complex. GLP-1 receptor agonists are well known for promoting weight loss and improving glycemic control, but scientists are increasingly examining how these medications influence muscle health …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.